A Phase 2, Open-Label, Single-Arm Study to Evaluate the

Project: Research project

Project Details

Description

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women with Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
StatusActive
Effective start/end date3/3/159/1/20

Funding

  • TESARO, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.